Stock detail
Alumis (ALMS) stock price, chart, and key data
View Alumis stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Alumis
ALMS · XNAS
-$3.54 (-14.66%) past month
$20.60
After hours $18.99 (0.00%)
Key metrics
Earnings
Past Income Statement
Close price
$18.99
Market cap
$2.4B
52-week range
$2.76 - $30.60
P/E ratio
-12.49
About the company
Alumis Inc
Alumis Inc is a clinical-stage biopharmaceutical company with an initial focus on developing its two Tyrosine Kinase 2 ("TYK2") inhibitors: envudeucitinib ("envu"), an allosteric TYK2 inhibitor for the treatment of PsO and SLE; and A-005, a central nervous system ("CNS") penetrant allosteric TYK2 inhibitor, to offer the therapeutic benefit of TYK2 inhibition within the CNS for a broad range of neuroinflammatory and neurodegenerative diseases.
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app